Guido Adler spends much of his time researching Cancer research, Internal medicine, Pancreatic cancer, Pancreas and Endocrinology. His work deals with themes such as Cell growth, Oncogene, Kinase, Cyclin D1 and Transdifferentiation, which intersect with Cancer research. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Surgery.
The Pancreatic cancer study combines topics in areas such as Tumor progression, Metastasis and Pancreatic disease. The various areas that Guido Adler examines in his Pancreas study include Carcinogenesis, Pathology, Nude mouse, In vivo and Adenocarcinoma. His Endocrinology study incorporates themes from Cholecystokinin, Cell culture, Fibronectin and Colitis.
His main research concerns Internal medicine, Endocrinology, Cancer research, Pancreas and Pancreatic cancer. His research integrates issues of Gastroenterology, Surgery and Oncology in his study of Internal medicine. His Endocrinology research is multidisciplinary, incorporating perspectives in Cholecystokinin and Extracellular matrix, Cell biology.
In his research, IκB kinase is intimately related to Kinase, which falls under the overarching field of Cancer research. His biological study focuses on Pancreatic disease. His Pancreatic cancer research includes elements of Tumor progression and Molecular biology.
Guido Adler mostly deals with Internal medicine, Cell biology, Endocrinology, Cancer research and Gastroenterology. His studies deal with areas such as Surgery and Oncology as well as Internal medicine. His research investigates the connection between Cell biology and topics such as Cell growth that intersect with problems in Genetically modified mouse, Keratinocyte growth factor and Protein kinase B.
His Endocrinology study combines topics in areas such as Immunohistochemistry, Hepcidin and Nerve growth factor. The study incorporates disciplines such as Endothelial stem cell, Cell, Rap1, Keratin and CA19-9 in addition to Cancer research. His Gastroenterology research integrates issues from Crohn's disease, Bone density and Group B.
His scientific interests lie mostly in Internal medicine, Cancer research, Cell biology, Molecular biology and Endocrinology. His Internal medicine research includes themes of Gastroenterology and Surgery. His research in Cancer research intersects with topics in Pancreatic carcinoma, Endothelium, CA19-9 and Rap1.
His study on Protein kinase A is often connected to Coatomer as part of broader study in Cell biology. His Molecular biology research incorporates elements of T cell, Immunology, Effector and CD40. His studies examine the connections between Endocrinology and genetics, as well as such issues in Hepcidin, with regards to Helicobacter pylori, Secretion, Stomach, Interleukin 6 and Western blot.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Identification, Culture, and Characterization of Pancreatic Stellate Cells in Rats and Humans
Max G. Bachem;Erik Schneider;Hans Groß;Hans Weidenbach.
Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells
Max G. Bachem;Marion Schünemann;Marco Ramadani;Marco Siech.
Transforming Growth Factor β1 Treatment Leads to an Epithelial-Mesenchymal Transdifferentiation of Pancreatic Cancer Cells Requiring Extracellular Signal-regulated Kinase 2 Activation
Volker Ellenrieder;Sandra F. Hendler;Wolfgang Boeck;Thomas Seufferlein.
Cancer Research (2001)
Metabolic and weight loss effects of long-term dietary intervention in obese patients: four-year results.
Marion Flechtner-Mors;Herwig H. Ditschuneit;Timothy D. Johnson;Mark A. Suchard.
Obesity Research (2000)
Suppression of NF-κB activity by sulfasalazine is mediated by direct inhibition of IκB kinases α and β
Christoph K. Weber;Susanne Liptay;Thomas Wirth;Guido Adler.
p300 Acts as a Transcriptional Coactivator for Mammalian Notch-1
Franz Oswald;Birgitt Täuber;Thomas Dobner;Soizic Bourteele.
Molecular and Cellular Biology (2001)
NF-κB/Rel activation in cerulein pancreatitis
Anne U. Steinle;Hans Weidenbach;Martin Wagner;Guido Adler.
Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin.
Patrick Michl;Malte Buchholz;Monika Rolke;Steffen Kunsch.
Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma.
Manfred P. Lutz;I.B.Silke Eßer;Berenike B.M. Flossmann-Kast;Roger Vogelmann.
Biochemical and Biophysical Research Communications (1998)
Claudin-4 Expression Decreases Invasiveness and Metastatic Potential of Pancreatic Cancer
Patrick Michl;Claudia Barth;Malte Buchholz;Markus M Lerch.
Cancer Research (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: